Literature DB >> 8578855

Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples.

L Stuyver1, A Wyseur, W van Arnhem, F Lunel, P Laurent-Puig, J M Pawlotsky, B Kleter, L Bassit, J Nkengasong, L J van Doorn.   

Abstract

To test the theoretical possibility of 5'-UR mistyping between hepatitis C virus subtypes 1a and 1b, we combined a 5'-UR/Core line probe assay (LiPA) with a nested PCR system and retested 183 sera, previously genotyped as type 1a or 1b and originating mainly from Western Europe. Eight percent of these were found to be wrongly subtyped. Based on this method, 3 additional subtypes of type 1 were discovered (1d-1f). Randomly selected European type 2 sera (n = 18) were tested with a similar type 2 5'-UR/Core LiPA. They were unexpectedly found to belong to subtype 2c in the majority of cases. Among serum samples originating from South-East Asia, several additional genotypes (7a, 7c, 7d, and 9a) were detected which had 5'-UR sequence motifs indistinguishable from genotype 1. Based on 13,203 pairwise comparisons in the 340-bp NS5B region, classification into types, subtypes, and isolates was obtained in 99.8% of all cases by using the phylogenetic border value of 0.328 for subtypes/types and 0.127 for isolates/subtypes; and evidence for a 10th major type of HCV was provided. Combination of all available HCV sequence data from the 447-bp Core/E1 region and the NS5B 340-bp and 222-bp regions provided evidence for the existence of 10 types, including 50 subtypes. Previously, extensive studies involving genotypes 1a, 1b, 2a, and 2b indicated the importance of HCV subtyping in interferon treatment and progression of chronic liver disease. The herein described expansion in the number of HCV types and subtypes should help improve diagnosis, treatment and possibly prophylaxis of hepatitis C liver disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578855     DOI: 10.1016/0168-1702(95)00052-r

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  42 in total

1.  Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients.

Authors:  Ahlem Djebbi; Selma Mejri; Valerie Thiers; Henda Triki
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Sequence heterogeneity of TT virus and closely related viruses.

Authors:  Y E Khudyakov; M E Cong; B Nichols; D Reed; X G Dou; S O Viazov; J Chang; M W Fried; I Williams; W Bower; S Lambert; M Purdy; M Roggendorf; H A Fields
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus.

Authors:  Suwanna Noppornpanth; Truong Xuan Lien; Yong Poovorawan; Saskia L Smits; Albert D M E Osterhaus; Bart L Haagmans
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Phylogenetic analysis of previously nontypeable hepatitis C virus isolates from Argentina.

Authors:  María Inés Gismondi; Pablo Daniel Becker; Pamela Valva; Carlos Alberto Guzmán; María Victoria Preciado
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

5.  Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).

Authors:  P Halfon; P Trimoulet; M Bourliere; H Khiri; V de Lédinghen; P Couzigou; J M Feryn; P Alcaraz; C Renou; H J Fleury; D Ouzan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

6.  Response of combination therapy on viral load and disease severity in chronic hepatitis C.

Authors:  Deepak Kumar; Abdul Malik; Mohammad Asim; Anita Chakravarti; Rakha H Das; Premashis Kar
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

7.  Subtyping genotype 2 hepatitis C viruses from Tunisia: identification of two putative new subtypes.

Authors:  Mouna Rajhi; Selma Mejri; Ahlem Djebbi; Soufiene Chouaieb; Imed Cheikh; Ahlem Ben Yahia; Amel Sadraoui; Walid Hammami; Msaddak Azouz; Nabil Ben Mami; Henda Triki
Journal:  Virus Genes       Date:  2013-11-23       Impact factor: 2.332

8.  Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping.

Authors:  S Le Pogam; F Dubois; R Christen; C Raby; A Cavicchini; A Goudeau
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

9.  Clinical relevance of hepatitis C virus genotypes.

Authors:  P Simmonds
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 10.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.